Reoperative Maxillofacial Oncology

Daniel Petrisor, Rui Fernandes

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


Approximately 36,000 people in the United States will be diagnosed with oral or oropharyngeal cancer in 2010. In more than 90% of the cases of oral cavity and oropharyngeal cancers, histopathologic examination reveals squamous cell carcinoma (SCCA). Despite appropriate initial treatment, oral SCCA recurs in 25% to 48% of cases. Several studies have shown that most cancers recur within about 2 years after the initial treatment. Hence, close follow-up of patients is important for the timely detection of recurrences. This article discusses the types of recurrence and the surveillance and treatment of recurrent oral SCCA.

Original languageEnglish (US)
Pages (from-to)161-168
Number of pages8
JournalOral and Maxillofacial Surgery Clinics of North America
Issue number1
StatePublished - Feb 2011
Externally publishedYes


  • Locoregional
  • Oropharyngeal
  • Radiotherapy
  • Recurrence

ASJC Scopus subject areas

  • Surgery
  • Oral Surgery
  • Otorhinolaryngology


Dive into the research topics of 'Reoperative Maxillofacial Oncology'. Together they form a unique fingerprint.

Cite this